TFC Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.6K | Sell |
102
-100
| -50% | -$52.5K | 0.01% | 252 |
|
|
2025
Q1 | $128K | Sell |
202
-70
| -26% | -$44.4K | 0.02% | 162 |
|
|
2024
Q4 | $194K | Buy |
272
+8
| +3% | +$5.7K | 0.03% | 128 |
|
|
2024
Q3 | $278K | Hold |
264
| – | – | 0.04% | 111 |
|
|
2024
Q2 | $277K | Buy |
264
+1
| +0.4% | +$1.05K | 0.05% | 97 |
|
|
2024
Q1 | $253K | Hold |
263
| – | – | 0.05% | 99 |
|
|
2023
Q4 | $231K | Hold |
263
| – | – | 0.05% | 103 |
|
|
2023
Q3 | $216K | Hold |
263
| – | – | 0.05% | 98 |
|
|
2023
Q2 | $189K | Buy |
263
+1
| +0.4% | +$719 | 0.05% | 114 |
|
|
2023
Q1 | $215K | Buy |
262
+1
| +0.4% | +$822 | 0.06% | 99 |
|
|
2022
Q4 | $188K | Hold |
261
| – | – | 0.05% | 97 |
|
|
2022
Q3 | $180K | Buy |
261
+160
| +158% | +$110K | 0.06% | 95 |
|
|
2022
Q2 | $60K | Buy |
101
+1
| +1% | +$594 | 0.02% | 190 |
|
|
2022
Q1 | $70K | Hold |
100
| – | – | 0.02% | 182 |
|
|
2021
Q4 | $63K | Buy |
100
+99
| +9,900% | +$62.4K | 0.02% | 201 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 537 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 541 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 590 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 585 |
|
|
2020
Q3 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 486 |
|